Clinical Trial Update: Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial completed evaluating Liposome Encapsulated SN38 (LE-SN38) in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LE-SN38 (liposome-encapsulated SN38) (SN38 encapsulated in liposomes)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Neoplasms | Phase 1 | Status: COMPLETED